Targeted therapy for pediatric central nervous system tumors harboring mutagenic tropomyosin receptor kinases

Overview of attention for article published in Frontiers in oncology, December 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 1 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 19,608 followers.

RT @FrontOncology: New research: Targeted therapy for pediatric central nervous system tumors harboring mutagenic tropomyosin receptor kina…

07 Dec 2023

Reply Repost Favourite

RT @FrontOncology: New research: Targeted therapy for pediatric central nervous system tumors harboring mutagenic tropomyosin receptor kina…

07 Dec 2023

Reply Repost Favourite

New research: Targeted therapy for pediatric central nervous system tumors harboring mutagenic tropomyosin receptor kinases: The family of the neurotrophic tyrosine kinase receptor (NTRK) gene encodes for members of the tropomyosin receptor… https://t.co/7

07 Dec 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.